Novo Nordisk and Eli Lilly may very well be producing adequate stock of semaglutide and tirzepatide to meet national demand, while patients still struggle to access the drugs due to logistical challenges
Accessed November 22, 2023
Design In the obesity trial, 338 participants (mean age 48 years, 48% women, mean BMI 37.3 kg/m 2 ) were randomised (2:1:1:1:1:2:2) to retatrutide 1 mg, 4 mg (titration), 4 mg (no titration), 8 mg (slow titration), 8 mg (fast titration), 12 mg or placebo over 48 weeks [45]
Proper injection technique, purchasing from reputable sources, and consulting with healthcare providers can help reduce the risk of side effects
For doses between 30-50 units, a 0.5mL (50-unit) syringe works well
This is the broadest range of GLP-1s we have tested at this price tier